Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
1.020
+0.031 (3.18%)
Nov 22, 2024, 4:00 PM EST - Market closed
Rallybio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -66.97 | -74.56 | -66.65 | -47.01 | -26.45 | -17.56 |
Depreciation & Amortization | 0.14 | 0.15 | 0.17 | 0.11 | 0.06 | 0.03 |
Loss (Gain) From Sale of Investments | -1.95 | -3.09 | -0.44 | - | - | - |
Loss (Gain) on Equity Investments | 2.42 | 2.04 | 1.08 | 1.51 | 1.52 | 0.1 |
Stock-Based Compensation | 8.58 | 10.92 | 9.5 | 3.65 | 0.7 | 0.19 |
Other Operating Activities | - | - | - | - | - | 0.14 |
Change in Accounts Payable | 0.13 | -0.1 | 0.49 | -0.98 | 0.72 | 0.73 |
Change in Other Net Operating Assets | 5.5 | 4.38 | -1.42 | -2.8 | 1.4 | 1.34 |
Operating Cash Flow | -51.07 | -60.27 | -57.28 | -45.53 | -22.04 | -15.03 |
Capital Expenditures | -0.01 | -0.01 | -0.05 | -0.33 | -0.14 | -0.19 |
Investment in Securities | 51.99 | 27.67 | -112.12 | -2 | -1.94 | - |
Investing Cash Flow | 51.97 | 27.66 | -112.17 | -2.33 | -2.07 | -0.19 |
Issuance of Common Stock | 5.52 | 0.28 | 51.77 | 86.2 | 145.21 | - |
Other Financing Activities | -0.27 | -0.14 | -0.69 | -3.23 | -0.32 | -0.03 |
Financing Cash Flow | 5.25 | 0.14 | 51.08 | 82.97 | 144.89 | 31.57 |
Net Cash Flow | 6.16 | -32.46 | -118.38 | 35.1 | 120.78 | 16.35 |
Free Cash Flow | -51.08 | -60.28 | -57.34 | -45.87 | -22.18 | -15.21 |
Free Cash Flow Per Share | -1.20 | -1.49 | -1.80 | -1.80 | -1.28 | -8.87 |
Levered Free Cash Flow | -26.26 | -34.15 | -33.77 | -28.91 | -12.75 | - |
Unlevered Free Cash Flow | -26.26 | -34.15 | -33.77 | -28.91 | -12.71 | - |
Change in Net Working Capital | -6.72 | -4.12 | 0.96 | 3.8 | -2.47 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.